MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4960 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2024-02-21 (twincities.com)
Twin Cities executive convicted of insider trading involving company’s acquisition by Medtronic
An executive at a Twin Cities medical device company has been convicted of insider trading for a scheme involving negotiations for the acquisition of the firm that was valued at $1.6 billion, feder...
Read more2023-05-04 (massdevice.com)
Stryker faces another bribery investigation
Stryker says the U.S. Justice Dept. and Securities and Exchange Commission contacted the company over potential antibribery law violations.
Read more2023-02-27 (fool.com)
Better Dividend Stock: Abbott Laboratories or Medtronic?
One of these top dividend stocks is a far more compelling buy today.
Read more(dotmed.com)
Former business VP charged with insider trading, securities fraud in $1.6 billion buyout of Mazor by Medtronic
Committed crimes over a two-year period
Read more(beckersspine.com)
Smith+Nephew records $5.5B in 2023 revenue
Discover the impressive growth of medtech company Smith+Nephew as they surpass $5 billion in 2023 revenue.
Read more(beckersspine.com)
Aclarion announces $3M public offering
Aclarion, a company focused on spine pain diagnostics, listed a $3 million public offering, the company said Feb. 26.
Read more(beckersspine.com)
Former NuVasive, LimaCorporate exec to lead Orthofix
Orthofix named Massimo Calafiore as its new president and CEO.
Read more(mpo-mag.com)
Lucas Buchanan Joins Endologix Board of Directors
Buchanan is currently CFO and chief operating officer at Silk Road Medical Inc.
Read more